Astec LifeSciences Limited has informed the Exchange that Board of Directors at its meeting held on June 24, 2025, has decided to issue equity shares on rights basis.
ASTEC · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 7.5 pts more than Nifty Microcap 250 and 7.6 pts more than its Pesticides & Agrochemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The Board of Directors of Astec LifeSciences Limited, held on June 24, 2025, approved issuing fully paid-up equity shares of face value Rs. 10 each, aggregating up to Rs. 250 Crore, through a Rights Issue to existing eligible shareholders. The specific terms such as issue price, entitlement ratio, record date, and payment schedule will be decided by the Board or a duly constituted committee at a later date. The issue will be carried out in accordance with the Companies Act, 2013 and SEBI ICDR Regulations, subject to necessary approvals. The document does not mention the specific purpose or use of proceeds for the fundraise.
Existing shareholders will get the opportunity (but not the obligation, depending on terms) to subscribe to additional shares, which could lead to dilution if they do not participate. The stock may see short-term volatility around the record date announcement, and the long-term impact will depend on the use of funds and the terms of pricing.